ADAM28 and precursor B-cell acute lymphoblastic leukemia: Prior work has shown that bone marrow levels of ADAM28 were increased in recently diagnosed B-ALL patients when compared to healthy controls, and that ADAM28 expression was significantly higher in B-ALL patients who relapsed compared to patients who continued in remission [84].